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Abstract 
Flat epithelial atypia (FEA) may represent the earliest precursor of low-grade breast cancer and often coexists with 
more advanced atypical proliferative breast lesions such as atypical ductal hyperplasia (ADH) and lobular 
intraepithelial neoplasia (LIN). The present study aims to investigate the association between morphological 
parameters of FEA and presence of malignancy at surgical excision (SE) and the clinical significance of the 
association of FEA stereotactic 11-gauge vacuum-assisted needle core biopsy (VANCB), reporting a diagnosis of FEA, 
ADH or LIN with subsequent SE from 14 pathology departments in Italy. 
Available slides were reviewed, with 114 (19.4 %) showing a malignant outcome at SE. Among the 190 cases of pure 
FEA, no statistically significant association emerged between clinical–pathological parameters of FEA and risk of 
malignancy. Logistic regression analyses showed an increased risk of malignancy according to the extension of ADH 
among the 275 cases of FEA associated with ADH (p00.004) and among the 34 cases of FEA associated with ADH 
and LIN (p00.02). In the whole series, a statistically significant increased malignancy risk emerged according to 
mammographic R1–R3/R4–R5 categories (OR01.56; p0 0.04), extension (OR01.24; p00.04) and grade (OR01.94; 
p00.004) of cytological atypia of FEA. The presence of ADH was associated with an increased malignancy risk 
(OR02.85; p<0.0001). Our data confirm the frequent association of FEA with ADH and/or LIN. A diagnosis of pure 
FEA on VANCB carries a 9.5 % risk of concurrent malignancy and thus warrants follow-up excision because none of 
the clinical–pathological parameters predicts which cases will present carcinoma on SE. 
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Introduction 
Widespread implementation of mammography screening programmes and the introduction of digital 
mammography in the pre-clinical diagnosis of breast lesions have led to an increasing number of core biopsies (CB) 
performed for nonpalpable nodules and microcalcifications. In the diagnostic assessment of microcalcifications, 
stereotactic 11-gauge vacuum-assisted needle core biopsy (VANCB) has a lower underestimation rate for 
malignancy than stereotactic 14-gauge needle core biopsy (NCB) 1. On CB performed for indeterminate or 
suspicious microcalcifications, a lesion designated as flat epithelial atypia (FEA) is frequently diagnosed. 
FEA, for which the term ductal intraepithelial neoplasia grade 1a (DIN1a) is also used, was introduced by the World 
Health Organization (WHO) Working Group on the Pathology and Genetics of Tumors of the Breast 2 with the aim 
of unifying columnar cell lesions with low-grade of cytological atypia, characteristically without complex 
architectural atypia in the form of arcades, bars, Roman bridges, tufts or micropapillae that are essential in 
distinguishing this lesion from atypical ductal hyperplasia (ADH or DIN1b). 
For FEA, a variety of terms has been proposed 3. Azzopardi 4 introduced the term clinging carcinoma in situ for this 
lesion, which can be mistaken for either normal breast tissue or fibrocystic breast change. Although the biological 
and clinical significance of FEA is still far from completely understood, emerging histological and molecular evidence 
suggests that FEA may represent the earliest morphologically identifiable non-obligatory precursor of low-grade 
breast cancer 5, 6. In fact, FEA often coexists with more advanced atypical proliferative breast 
lesions such as ADH and atypical lobular hyperplasia (LIN1/ALH) or low-grade ductal carcinoma in situ (DCIS, 
particularly micropapillary and cribriform type), lobular carcinoma 
in situ (LIN2/LCIS), tubular carcinoma and invasive lobular carcinoma (ILC) [7–12]. Otherwise, the possibility that 
columnar cell lesions in general and FEA in particular significantly elevate breast cancer risk is at the moment not 
well supported 13, 14. From a clinical point of view, a diagnosis of FEA on CB, pure or in association with more 
advanced atypical proliferative breast lesions, impacts on the management of these patients. Based on the 
underestimated malignancy rates of patients with a CB diagnosis of FEA, the prevailing recommendation 
remains surgical excision (SE) 15. 
The aims of our study were to evaluate: (1) if morphological parameters of pure FEA can predict malignancy (DCIS 
or invasive carcinoma) in subsequently performed SE, (2) the frequency of association of FEA with more advanced 
atypical proliferative breast lesions such as ADH 
and/or lobular intraepithelial neoplasia (LIN) and (3) the clinical significance of ADH and or LIN associated with FEA 
in terms of finding DCIS or invasive carcinoma in subsequently performed SE. 
 
 
Materials and methods 
The study population of a large Italian multi-institutional series of stereotactic VANCB, performed using an 11-gauge 
stereotactic vacuum-assisted device (Mammotome®, Ethicon 
Endo-Surgery, Breast Care, Norderstedt, Germany), has been previously reported 1. Of 22 institutions participating 
in that study, 14 agreed to proceed with a histological review 
of all VANCB and SE specimens: eight from Northern Italy, three from Central Italy and three from Southern Italy.  
Institutional review board approvals were obtained for the study from each participating centre. 
Pathology departments participating in the study were asked to retrieve from their archival files all available slides 
of consecutive B3 cases from VANCB specimens related to the study period 1 and reported in the original 
histological diagnosis as FEA, atypical epithelial proliferation of ductal type/ADH and LIN. In all participating 
pathology departments, once a diagnosis of FEA was considered, at least three additional levels of sectioning of 
VANCB, generally taken approximately at 25 μm apart, were routinely performed in view of the possibility of 
coexisting more advanced atypical proliferative breast lesions such as ADH and LIN1/ALH. Only VANCB 
cases with subsequent SE were included in this study. 
Radiology departments participating in the study were asked to provide for each case the age of patient, 
mammographic pattern (microcalcifications versus other patterns), mammographic category according to BIRADS 
(Breast Imaging Reporting and Data System) five-point (R1-R5) classification system 16, number of tissue cores 
obtained (12, 13–20, 21+) and presence of residual microcalcifications on post-stereotactic VANCB radiograms. 
 
 
Fig. 1 Pure flat epithelial atypia: dilated acinar unit lined by a single 
cell layer of columnar epithelial cells that show mild cytological atypia 
characterized by relatively round and monotonous nuclei 
 
 
 
 
 
 
 
 
 
Fig. 2 Pure flat epithelial atypia formed from columnar cells showing 
mild (left and right) to moderate (centre) nuclear atypia with an 
increased nuclear–cytoplasmic ratio 
 
 
 
 
 
 
 
 
 
Fig. 3 Atypical ductal hyperplasia arising in a background of flat 
epithelial atypia: part of the acinus is lined by only a few layers of 
atypical cells (left); on the right, the acinus shows a more complex 
architectural atypia with formation of bridges and fenestrations. 
Atypical 
ductal hyperplasia is composed of cells cytologically identical to 
those in the areas of flat epithelial atypia 
 
 
 
 
 
Fig. 4 Terminal duct lobular unit concurrently affected by lobular 
intraepithelial neoplasia (left), columnar cell change (centre and right) 
and flat epithelial atypia (lower right) 
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Table 1 Distribution of the final histological outcomes after surgical excision and percentages of malignancy according to the 
VANCB-reviewed histological diagnoses among 589 study cases of pure or associated FEA. Heterogeneity p value <0.0001 
 
Mention of FEA at 
VANCB 
Diagnosis at surgical excision  Total 
 
 Benign, N Atypia, N Malignancy  
   N % 
 
 
Pure FEA 73 99 18 9.5 190 (32.2 %) 
FEA + ADH 72 128 75 27.3 275 (46.7 %) 
FEA + LIN 17 60 13 14.4 90 (15.3 %) 
FEA + ADH + LIN 5 21 8 23.5 34 (5.8 %) 
Total 167 (28.4 %) 308 (52.3 %) 114 (19.4 %) 589 (100 %) 
  
 
An electronic spreadsheet to record clinical, radiological and histological data was used. Each pathologist 
participating in the study reviewed all haematoxylin & eosin (H&E) and immunohistochemically stained slides, when 
routinely obtained, of his/her own VANCB cases. The following morphological parameters were evaluated: (a) 
presence of determinant microcalcifications within the index lesion, (b) presence of unrelated microcalcifications, 
(c) patterns of FEA (cystically dilated glands, blunt duct adenosis (BDA) resembling pattern on low power, presence 
of apocrine features as reported by Kunju et al. 11), (d) grade of cytological atypia of FEA: mild atypia (characterized 
by relatively round or ovoid rather than elongated nuclei with a slight increase in the nuclear/cytoplasmic ratio, 
finely dispersed chromatin or slight margination of chromatin, variably prominent nucleoli and loss of polarity) or 
moderate atypia 
(characterized by enlarged, more oval nuclei with cytologically atypical features includingmild tomoderate 
pleomorphism, prominent nucleoli, some clumping of chromatin and increased 
nuclear/cytoplasmic ratio) as described by Pinder et al. 17, 18, (e) patterns of ADH (cribriform, micropapillary, solid or 
with presence of apocrine features) according to Kunju et al. 11, (f) patterns of LIN (LIN1/ALH or LIN2/LCIS), (g) 
presence of chronic inflammation and (h) presence 
of stromal changes including fibrosis and myxoid change. 
FEA was diagnosed according to strict morphological criteria 2, 19: variably distended acini lined by one to several 
layers of monotonous, mildly or moderately atypical, cuboidal to columnar cells growing in an exclusively flat 
pattern in the complete absence of architecturally atypical intraluminal proliferations. The presence of a single 
atypical intraluminal structure as arcade, bar, Roman bridge, tuft or micropapillary formation was considered 
enough for 
a diagnosis of FEA associated with concomitant ADH. 
ADH was diagnosed using combined histological and cytological criteria as established by Page and Rogers 20: a 
proliferative lesion that fulfils some but not all qualitative criteria for a diagnosis of intraductal carcinoma, i.e. 
evenly spaced cells with hyperchromatic nuclei coexisting with patterns of usual ductal hyperplasia or columnar cell 
changes, producing a partial involvement of glandular structure by neoplastic cells. In CB histology, technical issues 
hamper the application of quantitative criteria in diagnosing ADH 21. 
In the histological revision, LIN was subdivided into atypical lobular hyperplasia (LIN1/ALH) and lobular carcinoma in 
situ (LIN2/LCIS). LIN1/ALH was defined by filling and distension of fewer than half of the terminal duct units of a 
lobule with uniform small dyscohesive cells, 
evenly spaced, with round nuclei and minimal pleomorphism. LIN2/LCIS was diagnosed when more than half of the 
acini in the terminal duct units were completely filled or distended 22. The presence of a single lobule with 
morphological characteristics of LIN1 or LIN2 was considered sufficient for a diagnosis of FEA associated with LIN. 
The extent of involvement was determined by evaluating the number of large ducts and/or terminal duct lobular 
units affected by FEA, ADH and LIN as described by Ely et al. 23 and Wagoner et al. 24. Cases were divided according 
the number of foci affected in: (a) cases confined to one focus, (b) cases limited to two foci, (c) cases limited to 
three foci and (d) cases with four or more foci. The reviewed VANCB final diagnoses were coded into seven 
categories as follows: pure FEA, pure ADH, pure LIN, FEA + ADH, FEA + LIN, ADH + LIN, FEA + ADH + LIN. 
 
Fig. 5 Percentage distribution 
of the histological types and 
grade (nuclear grade for DCIS 
and histological grade for 
invasive carcinomas) of 
malignancies, as diagnosed at 
surgical excision, according to 
VANCB diagnosis 
 
 
Table 2 Distribution of 190 patients with a VANCB diagnosis of pure FEA according to the final histological outcome at surgical excision 
(malignancy yes/no) and several FEA-related variables. ORs from logistic analyses (95 % CIs and p values) for each variable as estimate 
of malignant breast cancer risk are also reported based on a model including terms for age and grade of cytological atypia of FEA 
 
  Malignancy at surgical excision Logistic analysis 
  Yes No p value OR  95 % CI p 
Mammographic 
category a 
R2–R3 8 105  1 
 
  
 R4–R5 10 67 0.17 2.15 0.78–5.77  
Mammographic 
pattern 
Microcalcificationsb 18 167 
 
    
Other  0 5 1.00c    
Determinant 
microcalcifications 
Yes 15 158  1 
 
  
 No 3 14 0.21c 2.57 0.64–10.43 0.19 
Number of cores 12 3 33     
 13–20 14 135     
 >20 1 4 0.52c 1.14d 0.34–3.81 0.83 
Chronic 
inflammation 
Yes 2 21  1 
 
  
 No 16 151 1.00c 1.33 0.82–6.39 0.72 
Stromal changes Yes 6 63  1   
 No 12 109 0.78 1.40 0.49–4.01 0.53 
Pattern of FEA BDA resembling 
pattern (reference) 
7 52  1 
 
  
 Cystically dilated 
glands 
11 105     
 Apocrine features 0 15 0.46c    
FEA with apocrine 
features 
Yes 0 15  1   
 No 18 157 0.37c    
Extension of FEA 1 focus 3 36     
 2 foci 2 40     
 3 foci 6 44     
 4+ foci 7 52 0.59c 1.23d 0.78–1.94 0.37 
Extension of FEA 
(dichotomous) 
1–2 foci 5 76  1 
 
  
 3+ foci 13 96 0.18 1.99 0.67–5.91 0.21 
Cytological atypia 
of FEA 
Mild grade 9 123  1 
 
  
 Moderate grade 9 49 0.06 2.41 0.90–6.45 0.08 
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a R2 mammographic category was reported in 1 case (0.5 %) and R5 mammographic category was reported in 4 cases (2.1 %) 
b In 48 cases (25.9 %), complete removal of microcalcifications was obtained; among them, two cases of malignancy were assessed at 
surgical excision 
c p values from Fisher exact tests 
dVariable included as an ordinal term in the logistic model. 
 
In each pathology department participating in the study, histology reports and slides of subsequent SE were 
collected. Each local pathologist reviewed all H&E slides of subsequent SE of his/her VANCB cases included in the 
study and reported them as: (a) malignant lesions specifying histotype, histological grade, size and lymph node 
status for invasive carcinoma, nuclear grade and size for DCIS and size for pleomorphic lobular carcinoma in situ, (b) 
atypical lesions specifying if FEA, ADH, ALH, LCIS were pure or in association and (c) benign lesions. Pathologists 
were asked to select for each VANCB case one or more representative H&Estained slides and, where appropriate, 
IHC-stained slides of the lesion to be reviewed jointly by the panel of 14 pathologists participating in the study. The 
selected slides of all VANCB cases included in the study were reviewed during a meeting organized at the Division of 
Pathological Anatomy of the University of Florence in September 2010 to obtain concordance on the diagnosis on 
each VANCB. Slides were reviewed using the Leica DMD108 digital microscope (Leitz Microsystems, Wetzlar, 
Germany) connected to a high-resolution data projector. In cases for which concordance was not reached, a 
majority diagnosis was established. No information about SE followup was provided during the panel revision. For 
the present analyses, only cases with a VANCB diagnosis of FEA (pure FEA, FEA + ADH, FEA + LIN, FEA + ADH + LIN) 
were considered. 
 
Table 3 Frequency of several FEA- and ADH-related variables among 275 patients with a VANCB diagnosis of 
combined FEA and ADH according to histological outcome at surgical excision (malignant yes/no). ORs from 
logistic analyses (95 % CIs and p values) for each variable as estimate of malignant breast cancer risk are also 
reported 
 
  Malignancy at 
surgical 
excision 
  Logistic 
analysis 
 
  
  Yes No p value ORb 95 % CI p 
Mammographic 
categorya 
R3 31 102  1 
 
  
 R4–R5 44 98 0.15 1.52 0.86–2.68 0.15 
 
Mammographic 
pattern 
Microcalcificationsd 75 193  1 
 
  
 Other 0 7  0.20e   
Determinant 
microcalcifications 
Yes 96 188  1   
 No 6 12 0.59e 1.54 0.51–4.69 0.45 
Number of cores 12 11 33     
 13–20 62 158     
 >20 2 8 0.81e 0.91c 0.46–1.79 0.78 
Chronic 
inflammation 
Yes 15 36  1   
 No 60 164 0.70 0.83 0.40–1.71 0.61 
Stromal changes Yes 29 74  1   
 No 46 126 0.80 0.95 0.53–1.71 0.87 
Pattern of FEA BDA resembling 
pattern (reference) 
28 83  1   
 Cystically dilated 
glands  
45 114  1.15 0.64–2.06 0.64 
 
 Apocrine features 2 3 0.68e 2.83 0.40–20.21 0.30 
FEA with apocrine 
features 
Yes 2 3  1 0.06–2.24 0.27 
 No 73 197 0.62e 0.38 0.06–2.66 0.33 
Extension of FEA 1 focus 8 34     
 2 foci 14 53     
 3 foci 15 38     
 4+ foci 38 75 0.16 1.17c 0.88–1.56 0.28 
Extension of FEA 1–2 foci 22 87  1   
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(dichotomous)  
 3+ foci 53 113 0.03 1.35 0.71–2.56 0.36 
Cytological atypia 
of FEA 
Mild grade 45 138  1 
 
  
 Moderate grade 30 62 0.16 1.50 0.84–2.67 0.17 
Pattern ADH Cribriform 
(reference) 
31 103  1 
 
  
 Micropapillar y 41 86  1.72 0.97–3.07 0.06 
 Solid 2 7  1.07 0.20–5.67 0.94 
 Apocrine features 1 4 0.40e 1.24 0.13–12.4 0.85 
ADH with 
apocrine features 
Yes 1 4  1 
 
  
 No 74 196 1.00e 2.69 0.21–34.56 0.45 
Extension of ADH 1 focus 15 64     
 2 foci 22 66     
 3 foci 13 38     
 4+ foci 25 32 0.01 1.45c 1.12–1.86 0.004 
Extension of ADH 
(dichotomous) 
1–2 foci 37 130  1 
 
  
 3+ foci 38 70 0.02 1.85 1.06–3.23 0.03 
 
a R5 mammographic category was reported in six (2.2 %) cases, while no cases were reported as R2 mammographic category 
b Adjusted for age, grade of cytological atypia of FEA, pattern of ADH, extension of ADH 
c Variable included as an ordinal term in the logistic model 
d In 50 (18.7%) cases, complete removal ofmicrocalcificationswas obtained; among them, five cases ofmalignancy were assessed 
after surgical excision 
e p values from Fisher exact test 
 
Statistical analysis 
The distribution of the histological diagnoses reported for the 859 VANCB specimens was 
calculated. The distribution of the histological diagnoses after SE (benign, atypical or malignant 
lesion) was also established as well as the percentage of cases with malignancy (according to 
each specific diagnosis at VANCB). 
For all cases with a diagnosis of FEA (pure or associated with other lesions), the distribution 
according to the following variables was calculated: mammographic category (R2–R3, R4–R5), 
mammographic pattern (microcalcifications, other), determinant microcalcifications (yes, no), 
number of cores (12, 13–20, >20), chronic inflammation (yes/no), stromal changes (yes/no), 
pattern of FEA (blunt duct adenosis resembling pattern, cystically dilated glands, apocrine 
features), extension of FEA (one focus, two foci, three foci, four foci or more), grade of 
cytological atypia of FEA (mild, moderate), pattern of ADH (cribriform, micropapillary, 
solid or with presence of apocrine features), extension of ADH (one focus, two foci, three foci, 
four foci or more), pattern of LIN (ALH/LIN1 or LCIS/LIN2), extension of LIN (one focus, two foci, 
three foci, four foci or more). P values from chi-square test or Fisher exact test were also 
calculated. Mean age at VANCB diagnosis according to malignant outcome (p values from 
between-mean comparison t tests) was also calculated. Logistic regression models were used to 
compute odd ratios (ORs) and 95 % confidence intervals (95 % CIs) for each FEA-related variable 
as estimate of malignant breast cancer risk. Logistic regression analyses were performed 
separately for a diagnosis on VANCB of pure FEA, of FEA + ADH, of FEA + LIN and of FEA +ADH + 
LIN. Logistic models were adjusted for age at VANCB diagnosis of the cases, grade of cytological 
atypia of FEA, pattern and extension of ADH or LIN or both, respectively. 
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Logistic regression analyses were also performed for all cases including a VANCB diagnosis of 
FEA (pure FEA or FEA + ADH or FEA + LIN or FEA + ADH +LIN). Logistic models were adjusted for 
age at VANCB diagnosis, grade of cytological atypia of FEA and copresence of ADH or LIN. 
 
Results 
A total of 859 histologically reviewed VANCB cases with a subsequent SE were available 
including pure FEA (Figs. 1 and 2) (N0190, 22.1 %), pure LIN (N0149, 17.3 %), pure ADH (N0108, 
12.6 %), FEA associated with ADH (Fig. 3) (N0275, 32.0 %), FEA associated with LIN (Fig. 4) (N090, 
10.5 %), ADH associated with LIN (N013, 1.5 %) and FEA associated with both ADH and LIN 
(N034, 4.0 %). Of 589 (68.6 %) cases with FEA (190 pure FEA and 399 FEA associated with ADH or 
LIN or ADH + LIN), 167(28.3 %) had a benign, 308 (52.3 %) an atypical (including LIN1 and LIN2) 
and 114 (19.4 %) a malignant outcome diagnosed on subsequent SE. A total of 18 malignancies 
among pure FEA, 75 malignancies among FEA + ADH, 13 malignancies among FEA + LIN and 8 
malignancies among FEA + ADH + LIN were diagnosed on SE, resulting in underestimation rates 
of 9.5, 27.3, 14.4 and 23.5%respectively (Table 1; heterogeneity p value <0.0001). As shown in 
Fig. 5, DCIS was the most frequent malignancy at SE among all the types of VANCB diagnosis. The 
median age of patients with pure FEA was 50.7 years, 51.9 years for FEA + ADH, 49.9 years for 
FEA + LIN and 52.6 years for FEA + ADH +LIN (data not shown). 
In Tables 2, 3, 4 and 5, the distribution of cases with a VANCB diagnosis of pure FEA, FEA + ADH, 
FEA + LIN and FEA + ADH + LIN, respectively, according to malignancy upon SE, and several FEA 
and/or ADH and/or LINrelated variables is reported together with the results of multivariate 
analyses. The risk of malignancy in women with moderate cytological atypia showed a trend 
towards being increased (Table 2) compared with that of women with mild cytological atypia (χ2 
test, p00.06). The suggestion was confirmed by logistic regression analysis (OR 2.41; p00.08). 
The suggestion that complete removal of microcalcifications was less frequently associated with 
malignancy (two cases out of 48 or 4.2 % showing malignancy at surgery) than incomplete 
removal was not statistically significant (16 out of 142 or 11.3 %). 
In Table 3 (FEA + ADH), an increased risk of malignancy according to the extension of ADH 
emerged in a model adjusted for age, grade of cytological atypia of FEA and pattern of ADH (OR 
1.45, p value 0.004). 
In Table 4 (FEA + LIN), an increased risk of malignancy in patients with a moderate grade of 
cytological atypia of FEA compared to patients with a mild grade of cytological atypia emerged 
(OR 5.22, p value 0.03). In Table 5 (FEA + ADH + LIN), an increased risk of malignancy according 
to the extension of ADH emerged (OR 6.71, p value 0.02). 
According to Table 6, women in the mammographic category R4–R5 had an increased risk of 
malignancy compared with those in R2–R3 category (OR 1.56, 95 % CI 1.01–2.39, p value 0.04). 
Women with an extension of FEA of three foci or more had an increased risk of malignancy 
compared with those with one or two foci (OR 1.73, 95 % CI 1.10–2.73, p value 0.02). Women 
with moderate grade of cytological atypia had an increased risk of malignancy compared 
with those with mild grade of cytological atypia (OR 1.94, 95 % CI 1.24–3.04, p 0.004). While the 
association of LIN with FEA at VANCB (FEA + LIN or FEA + ADH + LIN) did not modulate the risk of 
a malignant outcome, the association of ADH (FEA + ADH or FEA + ADH + LIN) was a strong 
predictor of malignancy at SE (OR 2.85, 95 % CI 1.78–4.58, p<0.0001). The mean age of women 
with malignancy at SE was significantly higher than that of women with a non-malignant 
outcome (53.4 vs 50.7 years, p00.001). 
 9
Table 4 Frequency of several FEA- and LIN-related variables among 90 patients with a VANCB diagnosis of FEA 
associated with L IN according to histological outcome at surgical excision (malignant yes/no). ORs from logistic 
analyses (95 % CIs and p values) for each variable as estimate of malignant breast cancer risk are also reported 
 
  Malignancy at surgical excision Logistic analysis 
 
  Yes No p value ORb 95 % CI p 
 
Mammographic categorya R3 6 42  1 
 
  
 R4–R5 7 35 0.57 1.58 0.42–
5.95 
0.5 
Mammographic pattern Microcalcificationsd 11 73  1 
 
  
 Other 2 4 0.21e 4.57 0.61–
34.52 
0.14 
Determinant 
microcalcifications 
Yes 12 58  1 
 
  
 No 1 9 0.28e 0.16 0.02–
1.63 
0.12 
 
Number of cores 12 2 7     
 13–20 9 63     
 >20 23 7 0.47e 1.70c 0.32–
9.20 
0.54 
Chronic inflammation Yes 3 7  1   
 No 10 70 0.15e 0.38 0.07–
2.08 
0.27 
Stromal changes Yes 4 28  1   
 No 9 49 0.77e 1.06 0.25–
4.46 
0.94 
 
Pattern of FEA B DA resembling pattern 
(reference) 
2 29  1 
 
  
 Cystically dilated glands 8 48 3.52  0.61–
20.35 
0.16 
 Apocrine features 3 0 0.002e    
FEA with apocrine features Yes 3 0  1   
 No 10 77 0.002e    
Extension of FEA 1 focus 6 27     
 2 foci 1 21     
 3 foci 2 12     
 4+ foci 4 17 0.50e 0.92c 0.53–
1.58 
0.75 
 
Extension of FEA 
(dichotomous) 
1-2 foci 7 48  1 
 
  
 3+ foci 6 29 0.56 1.06 0.29–
3.85 
0.93 
Cytological atypia of FEA Mild grade 9 70  1 
 
  
 Moderate grade 4 7 0.05e 5.22 1.16–
23.53 
0.03 
Pattern of LIN LIN1/ALH 10 42  1 
 
  
 LIN2/LCIS 3 35 0.22e 0.38 0.09–
1.53 
0.17 
Extension of LIN 1 focus 3 22     
 2 foci 3 19     
 3 foci 3 14     
 4+ foci 4 22 0.98e 1.26c 0.73–
2.19 
0.41 
 
Extension of LIN 
(dichotomous) 
1–2 foci 6 41  1 
 
  
 3+ foci 7 36 0.64 1.58 0.45–
5.58 
0.48 
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a R5 mammographic category was reported in one (1.1 %) case, while no cases were reported as R2 mammographic 
category 
b Adjusted for age, cytological atypia of FEA, pattern of LIN, extension of LIN 
c ariable included as an ordinal term in the logistic model. 
d In 17 (20.2 %) cases, complete removal of microcalcifications was obtained; among them, no cases of malignancy 
were assessed after surgical 
excision 
e p values from Fisher exact tests 
 
Table 5 Frequency of several FEA-, ADH- and LIN-related variables among 34 patients with a ANCB diagnosis of 
FEA associated with ADH and LIN according to histological outcome after surgical excision (malignant yes/no). 
ORs from logistic analyses (95 % CIs and p values) for each variable as estimate of malignant breast cancer risk 
are also reported 
 
  Malignancy at surgical excision Logistic analysis 
  Yes No p value ORb 95 % CI p 
Mammographic 
categorya 
R3 4 12  1   
 R4 4 14 1.00e 1.51 0.08–28.34 0.78 
 
Mammographic 
pattern 
Microcalcificationd 8 25  1 
 
  
 Other 0 1 1.00    
Determinant 
microcalcifications 
Yes 7 19  1 
 
  
 No 1 7 0.64e 2.89 0.09–89.38 0.54 
 
Number of cores 12 1 3 
 
    
 13–20 6 21     
 >20 1 2 1.00e 0.85c 0.09–7.97 0.88 
 
Chronic inflammation Yes 1 1  1   
 N o 7 25 0.42e 1.09 0.003–
474.86 
0.98 
Stromal changes Yes 3 5  1   
 No 5 21 0.36e 0.05 0.001–2.23 0.12 
Pattern of FEA BDA-resembling 
pattern (reference) 
3 8  1 
 
  
 Cystically dilated 
glands 
4 16  0.47 0.02–10.90 0.64 
 
 Apocrine features 1 2 0.72e    
Apocrine features of 
FEA 
Yes 1 2  1 
 
  
 No 7 24 1.00e 0.06 0.001–3.40 0.17 
Extension of FEA 1 focus 2 8     
 2 foci 0 7     
 3 foci 1 2 
 
    
 4+ foci 5 9 0.31e 0.59c 0.16–2.19 0.43 
Extension of FEA 
(dichotomous) 
1–2 foci 2 15  1   
 3+ foci 6 11 0.22e 0.60 0.03–10.36 0.72 
Cytological atypia of 
FEA 
Mild grade 5 22  1 
 
  
 Moderate grade 3 4 0.32e 1.35 0.11–17.24 0.82 
 
Pattern ADH Cribriform (reference) 3 11  1 
 
  
 Micropapillary 3 10 4.79  0.14–170.30 0.39 
 Solid 1 1     
 Apocrine features 1 4 0.85e    
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Apocrine features of 
ADH 
Yes 1 4  1 
 
  
 No 7 22 1.00e 0.16 0.01–4.29 0.27 
Extension of ADH 1 focus 2 15     
 2 foci 0 6     
 3 foci 1 2     
 4+ foci 5 3 0.02e 6.71c 1.30–34.77 0.02 
Extension of ADH 
(dichotomous) 
1–2 foci 2 21  1 
 
  
 3+ foci 6 5 0.007e 86.38 2.26–>999.9 0.02 
 
Pattern of LIN LIN1/ALH 3 16  1 
 
  
 LIN2/LCIS 5 10 0.42e 3.12 0.33–29.64 0.32 
Extension of LIN 1 focus 1 6 
 
    
 2 foci 3 6     
 3 foci 0 5     
 4+ foci 4 9 0.51e 0.46c 0.13–1.61 0.23 
Extension of LIN 
(dichotomous) 
1–2 foci 4 12 1    
3+ foci 4 14 1.00e 0.04  0.001–1.68 0.09 
 
 
a No cases were reported as R2 or R5 mammographic category 
b Adjusted for age, cytological atypia of FEA, pattern of ADH, extension of ADH, pattern of LIN, extension of LIN 
c ariable included as an ordinal term in the logistic model. 
d In 12 (36.4 %) cases, complete removal of microcalcifications was obtained; among them, two cases of malignancy 
were assessed after surgical excision 
e p values from Fisher exact tests 
 
Discussion 
Our study, although limited by its retrospective design, to the best of our knowledge, represents 
the largest series published to date of FEA, pure or in association with more advanced lesions 
such as ADH and or LIN, diagnosed on stereotactic 11-gauge VANCB with subsequent follow-up 
surgical excision. It may contribute to the assessment of the clinical and biological significance 
of pure FEA and to the management of patients with VANCB diagnosis of pure FEA. All VANCB 
cases were histologically reviewed and diagnoses were agreed by the panel of 14 pathologists 
participating in the study using non-ambiguous terminology 25, 26. 
 
Pure FEA 
On CB performed for indeterminate or suspicious microcalcifications, a lesion designated as flat 
epithelial atypia is increasingly recognized and diagnosed 1. The preoperative histological 
diagnosis of FEA poses a management dilemma for the clinician. Although there is no definitive 
agreement at present on the clinical management of FEA (underestimation rates for CB 
diagnosis of pure FEA reported in the literature vary from 0 to 67 % 13), the currently prevailing 
recommendation is that it warrants follow-up surgical excision 1, 27. A few studies in the 
published literature support the follow-up observation for the management of pure FEA 26, 28, 29. 
A recent review 15 reported a pooled underestimation rate of 12 % for FEA in VANCB (in good 
agreement with our 12.7 % 1) compared to 17 % in studies restricted to NCB (difference not 
statistically significant). Consequently, the authors concluded that surgical excision should be 
considered. On the other hand, the data reported mostly concern small series (range 1–60 
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cases), partly published only in abstract form, mostly lacking standardized terminology (including 
pure FEA and FEA with ADH and or LIN). No single or a combination of 
clinical, radiological or pathological criteria clearly identified a subset of pure FEA cases at low 
risk of malignancy. Thus, our results and other recent data 27 justify the conclusion that the 
presence of pure FEA on VANCB warrants follow-up excision. 
The identification of FEA also poses a diagnostic challenge to the pathologist, particularly in CB, 
because FEA with mild cytological atypia may be subtle and care should be taken not to overlook 
the lesion or to over-diagnose it and reporting as atypical any columnar cell lesion 17, 18. 
Our results confirm previous reports 11, 25–27 that almost all patients (185/190, 97.4 %) with pure 
FEA are asymptomatic and that microcalcifications are the main determinant in 91 % (173/190) 
of cases. As earlier studies reported 11, we found moderate to severe chronic inflammation in 12 
% of pure FEA cases (23/190) and stromal changes, including myxoid change and fibrosis in 36.3 
% (69/190), of which the significance remains to be clarified. 
 
Table 6 Frequency of several FEA-related variables among 589 patients with a mention of FEA in the VANCB 
diagnosis (pure FEA or FEA associated with ADH or LIN or ADH + LIN) according to 
histological outcome after surgical excision (malignant yes/no). ORs from logistic analyses (95 % CIs and p values) 
for each variable as estimate of malignant breast cancer risk are also reported 
 
  Malignancy at surgical excision Logistic analysis 
  Yes No p value ORb 95 % CI p 
Mammographic 
categorya 
R2–R3 49 261  1 
 
  
 R4-R5 65 214 0.02 1.56 1.01–2.39 0.04 
Mammographic 
pattern 
Microcalcificationsd 112 458  1 
 
  
 Other 2 17 0.55e 0.55 0.12–2.52 0.44 
Determinant 
microcalcifications 
Yes 103 423  1 
 
  
 No 11 52 0.69 1.01 0.49–2.10 0.98 
Pattern of FEA BDA-resembling 
pattern (reference) 
40 172  1 
 
  
 Cystically dilated 
glands 
68 283 1.18  0.75–1.86 0.48 
 Apocrine features 6 20 0.88 1.90 0.68–5.29 0.22 
Apocrine features 
of FEA 
Yes 6 20  1   
 No 108 455 0.62 0.59 0.22–1.56 0.28 
Extension of FEA 1 focus 19 105 
 
    
 2 foci 17 121     
 3 foci 24 96     
 4+ foci 54 153 0.01 1.24c 1.02–1.50 0.04 
Extension of FEA 
(dichotomous) 
1–2 f oci 36 226  1   
 3+ foci 78 249 0.002 1.73 1.10–2.73 0.02 
 
C ytological atypia 
of FEA 
Mild grade 68 353  1   
 Moderate grade 46 122 0.02 1.94 1.24–3.04 0.004 
Number of cores 12 17 76     
 13–20 91 377     
 >20 6 21 0.9 1.05c 0.63–1.74 0.85 
Chronic 
inflammation 
Yes 21 65  1   
 No 93 410 0.2 0.79 0.44–1.39 0.41 
Stromal changes Yes 42 170  1   
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 No 72 305 0.83 0.96 0.61–1.49 0.84 
 
Association with 
ADH 
Yes 83 226  1   
 No 31 249 <0.0001 2.85 1.78–4.58 <0.0001 
Association with 
LIN 
Yes 21 103  1   
 No 93 372 0.44 1.32 0.75–2.33 0.34 
 
a R2 Adjusted for age, cytological atypia of FEA, co-presence of ADH and/or LIN 
c ariable included as an ordinal term in the logistic model. 
d In 127 (22.3 %) cases, complete removal of microcalcifications was obtained; among them, nine cases of 
malignancy were assessed after surgical excision 
e p values from Fisher exact tests 
 
FEA associated with ADH 
Although FEAmay occur as pure lesion, a large proportion (275/589 or 46.7 %) is associated with 
ADH, in agreementwith earlier reports 11, 12, 26, 27, 30. The association of FEA with ADH has an 
important impact on clinical management as for ADH on CB the need for surgical excision is 
unanimously recognized 31. The positive predictive value for malignancy of FEA associated with 
ADH on CB significantly increases when compared to that of pure FEA 11, 26. We found that 27.3 
% (75/275) of FEA associated with ADH showed a malignancy at follow-up SE. Our study 
confirms the strong association between FEA and ADH on CB. Our data, together with data from 
other observational 26 and molecular studies 5–6 support the hypothesis that FEA represents the 
earliest precursor of low-grade ductal carcinoma, both in situ and invasive 19. 
FEA associated with LIN Some investigators have reported the coexistence of FEA and LIN in the 
same surgical specimen, particularly in cases of tubular carcinoma 7, 32, 33. Recently, Abdel-Fatah 
et al. 8 found that columnar cell lesions, predominantly FEA, and LIN coexist in 60 % of cases of 
ILC, suggesting that the loss of E-cadherin expression may switch on the development of lobular 
differentiation, and proposed an evolutionary pathway f ILC through columnar cell lesions on the 
basis of histological evidence and common genetic changes. 
We found FEA associated with LIN in 15.3 % (90/589) of cases, in agreement with data reported 
by Levoue et al. 27, which results in a malignancy underestimation rate of 14.4 %.  
 
FEA associated with ADH and LIN 
In 5.8 % (34/589) of our cases, we found FEA associated both with ADH and LIN, resulting in an 
underestimation rate of malignancy of 23.5 %, which is closer to the underestimation 
rate of FEA + ADH (27.3 %) than that of FEA +LIN (14.4 %). This indicates that ADH determines 
the natural history of the lesion. In FEA associated with both ADH and LIN, the extension of ADH 
seems to be strongly associated with the risk of malignancy. 
Taken together, in our series 19.4 % (114/589) of cases with a mention of FEA (pure FEA and/or 
FEA associated to ADH and/or LIN) showed a malignancy at subsequent SE. 
The risk of malignancy increased along with the mammographic category, the extension of FEA 
and the grade of cytological atypia of FEA, while the association with ADH was a strong predictor 
of malignancy. The median age of patients with pure FEA was slightly younger than that of 
patients with FEA + ADH and FEA + ADH + LIN (50.7, 51.9 and 52.6 years, respectively) but 
slightly older compared to those with FEA + LIN (49.9 years, as reported earlier) [11, 26]. 
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Conclusion 
None of the studied parameters of pure FEA can predict the risk of malignancy in a subsequent 
SE. A trend was found only for the grade of cytological atypia (mild versus moderate) and 
incomplete removal of microcalcifications. 
In FEA associated with ADH or ADH and LIN, the risk of malignancy increases along with 
increasing extension of ADH. In FEA associated with LIN, the risk of malignancy is higher in case 
of moderate cytological atypia of FEA. The risk of malignancy in FEA increased according to 
mammographic category, extension of FEA and grade of cytological atypia of FEA. 
A diagnosis of pure FEA on VANCB warrants SE because, on the basis of clinical–pathological 
parameters, it is impossible to predict which cases are associated with carcinoma. 
The absence of residual microcalcifications on post-VANCB mammography does not exclude the 
presence of an associated malignancy at SE: we found malignancy in 4 % (2/48), 10 % (5/50) and 
16.7 % (2/12) of cases with complete removal of microcalcifications by VANCB in pure FEA, FEA + 
ADH and FEA + ADH + LIN, respectively. 
We therefore confirm the frequent association of FEA with more advanced atypical proliferative 
breast lesions such as ADH and/or LIN [17–19, 34] and support the recommendation proposed 
by several authors 25, 30 that deeper levels of CB with pure FEA should be examined in order to 
detect or exclude the co-existence of more advanced breast lesions. The findings concerning the 
frequent association of FEA with more advanced atypical proliferative breast lesions support the 
hypothesis that FEA, together with ADH and LIN, belongs to the family of precursor lesions of 
low grade in situ and invasive breast cancer [5, 8] as the earliest precursor recognized to date. 
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